46例甲状腺髓样癌临床诊治分析

来源 :第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 | 被引量 : 0次 | 上传用户:yunpiaosifang
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  目的:分析散发性甲状腺髓样癌(SMTC)的临床治疗方法,探讨相关肿瘤指标在其诊断及预后中的应用.方法:回顾性分析2000-2010年期间我院收治的46例散发性甲状腺髓样癌患者的临床资料.结果: 46例散发性甲状腺髓样癌中,占同期收治甲状腺髓样癌的78.3%,占甲状腺癌的2.2%.
其他文献
  目的: Pemetrexed (P) is the standard of care for non-squamous non-small cell lung cancer (NS NSCLC), whereas epidermal growth factor receptor (EGFR) tyrosine
会议
  Objective: To investigate the clinical outcomes and toxicity of stereotactic body radiotherapy (SBRT) with amoderate dose fraction for medically inoperable
会议
  Objective: Treatment options for pts with advanced SCC of the lung progressing after platinum-based chemotherapy are limited.Over expression of EGFR, other
会议
  Objective: Immunohistochemistry (IHC) and fluorescent in situ hybridization (FISH) are reliable ways to identify over expression of c-Met protein or amplifi
会议
  Objective: Nivo, a fully human IgG4 programmed death-1 immune checkpoint inhibitor antibody, has demonstrated durable responses and tolerability in heavily
会议
  Objective: The cellular-mesenchymal-epithelial transition protein (MET) has recently been identified as a novel promising target in non-small-cell lung canc
会议
  Objective: Amplifications and activating mutations in the c-MET proto-oncogene are known oncogenic drivers that have proven responsive to targeted therapy.
会议
  目的:探讨常规超声对甲状腺滤泡病变鉴别诊断的价值。方法:选择2004年至2014年在北京协和医院就诊并被病理证实的59例滤泡癌,以性别、年龄作为匹配条件,随机从病历数据库中选
  目的:中医治疗恶性肿瘤可提高疗效,减轻化疗的不良反应。中西医结合是我国治疗恶性肿瘤的特色。方法:治疗前均签署知情同意书。两组均采用TPF方案化疗,多西他赛(深圳万乐)7
会议
  目的:探讨术后131I治疗前刺激性甲状腺球蛋白(ps-Tg)< 10ng/ml的非远处转移性分化型甲状腺癌(DTC)患者经131I治疗后的临床转归,以及ps-Tg对DTC患者临床转归的预测价值.方法:2